REFERENCES
- Nickel JC, Downey J, Hunter D et al. Prevalence of pro-statitis-like symptoms in a population-based study employing the National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI). J Urol. 2001; 165: 842–845.
- Workshop Committee of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Chronic Prostatitis Workshop, Bethesda, MD, 7–8 December 1995.
- Meares EM Jr, Stamey TA. Bacterial localization patterns in bacterial prostatitis and urethritis. Invest Urol 1968; 5: 492–518.
- Litwin MS, McNaughton-Collins M, Fowler Jr FJ, et al. The National Institutes of Health Chronic Prostatitis Symptom Index: development and validation of a new outcome measure. J Urol 1999; 162: 369–75.
- Wagenlehner F.M.E., Naber K.G. Fluoroquinolone antimi-crobial agent in the treatment of prostatitis and recurrent urinary tract infections in men. Curr Urol Rep 2004 Aug; 5 (4): 309–16.
- Nickel JC. a-Blockers for Treatment of the Prostatitis Syn-dromes. Rev Urol 2005; 7 (Suppl 8): S18–25.
- Schaeffer A.J. NDDK-sponsored Chronic Prostatitis Col-laborative Research Network (CPCRN) 5-year data and treatment guidelines for bacterial prostatitis. Int J Antimicrob Agents. 2004; 24 (5): S53–S56.
- Sadeghi-Nejad H, Seftel A. Sexual dysfunction and prosta-titis. Curr Urol Rep. 2006; 7 (6): 479–84.
- Nickel JC. The Pre and Post Massage Test (PPMT): a sim-ple screen for prostatitis. Tech Urol 1997; 3: 38–43.
- Naber KG. Management of bacterial prostatitis: What's new? Review. BJU Int. 2008; 101 Suppl 3: 7–10.
- Naber KG, Rocher K, Sotto H, et al. Oral levofloxacin 500 mg once daily in the treatment of chronic bacterial prostatitis. Int J Antimicrob Agents (2008), doi: 10.1016/ ijantim-icag.200803.014.
- Taylor BC, Noorballochi S, McNaughton-Collins M et al. Urologic Diseases in America Project. Am J Med 2008; 121 (5): 444–9.
- Skerk V, Krhen I, Schonwald S et al. The role of unusual pathogens in postatitis syndrome. Int J Antimicrob Agents. 2004; 24 (5): S53–S56.
- Sobel J, Kaye D. Urinary Tract Infections, in Mandell, Douglas and Bennett's Principles and Practice of Infectious Dis-eases, Volume 1, Chapter 66, Elsevier. Sixth Edition, 2005: 894.
- Wagenlehner FME, Naber KG. Current challenges in the treatment of complicated urinary tract infections and prostatitis. Clin Microbiol Infect 2006; 12 (Suppl 3): 67–80.
- Krieger JN, Lee SW, Jeon J et al. Epidemiology of pro-statitis. Int J Antimicrob Agents 2008; 31 Suppl 1: S85–90.
- Krieger JN. Classification, epidemiology and implications of chronic prostatitis in North America, Europe and Asia. Min-erva Urol Nefrol. 2004; 56 (2): 99–107.